Integrative Analysis of Transcriptome and Metabolome to Illuminate the Protective Effects of Didymin against Acute Hepatic Injury
Mediators of Inflammation · 2023
DOI: 10.1155/2023/6051946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, 2023. Verfasst von Lijun Pang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Medical University, Nanning 530021, China. Hauptthemen laut MEDLINE: NF-kappa B, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangxi Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Based on the multiomics analysis, this study is aimed at investigating the underlying mechanism of didymin against acute liver injury (ALI). The mice were administrated with didymin for 2 weeks, followed by injection with lipopolysaccharide (LPS) plus D-galactosamine (D-Gal) to induce ALI. The pathological examination revealed that didymin significantly ameliorated LPS/D-Gal-induced hepatic damage. Also, it markedly reduced proinflammatory cytokines release by inhibiting the TLR4/NF-κB pathway activation, alleviating inflammatory injury. A transcriptome analysis proved 2680 differently expressed genes (DEGs) between the model and didymin groups and suggested that the PI3K/Akt and metabolic pathways might be the most relevant targets. Meanwhile, the metabolome analysis revealed 67 differently expressed metabolites (DEMs) between the didymin and model groups that were mainly clustered into the glycerophospholipid metabolism, which was consistent with the transcriptome study. Importantly, a comprehensive analysis of both the omics indicated a strong correlation between the DEGs and DEMs, and an in-depth study demonstrated that didymin alleviated metabolic disorder and hepatocyte injury likely by inhibiting the glycerophospholipid metabolism pathway through the regulation of PLA2G4B, LPCAT3, and CEPT1 expression. In conclusion, this study demonstrates that didymin can ameliorate LPS/D-Gal-induced ALI by inhibiting the glycerophospholipid metabolism and PI3K/Akt and TLR4/NF-κB pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guangxi Medical University, Nanning 530021, China.
- The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530023, China.
ORCID-Profile: Yuhua Xiong, Quanfang Huang, Xing Lin
Förderung
- Natural Science Foundation of Guangxi Province
- National Natural Science Foundation of China
Zitieren
APA
Pang, L., Xiong, Y., Feng, Z., Li, C., Fang, B., Huang, Q., & Lin, X. (2023). Integrative Analysis of Transcriptome and Metabolome to Illuminate the Protective Effects of Didymin against Acute Hepatic Injury. Mediators of Inflammation. https://doi.org/10.1155/2023/6051946
Vancouver
Pang L, Xiong Y, Feng Z, Li C, Fang B, Huang Q, et al. Integrative Analysis of Transcriptome and Metabolome to Illuminate the Protective Effects of Didymin against Acute Hepatic Injury. Mediators of Inflammation. 2023. doi:10.1155/2023/6051946
BibTeX
@article{Pang2023,
author = {Pang, Lijun and Xiong, Yuhua and Feng, Zhongwen and Li, Cuiyu and Fang, Bin and Huang, Quanfang and Lin, Xing},
title = {Integrative Analysis of Transcriptome and Metabolome to Illuminate the Protective Effects of Didymin against Acute Hepatic Injury},
journal = {Mediators of Inflammation},
year = {2023},
doi = {10.1155/2023/6051946}
}
EUVIMED